[go: up one dir, main page]

DK0881901T3 - Kombination af aktive stoffer, der indeholder clopidogrel og et antithrombotisk middel - Google Patents

Kombination af aktive stoffer, der indeholder clopidogrel og et antithrombotisk middel

Info

Publication number
DK0881901T3
DK0881901T3 DK97905218T DK97905218T DK0881901T3 DK 0881901 T3 DK0881901 T3 DK 0881901T3 DK 97905218 T DK97905218 T DK 97905218T DK 97905218 T DK97905218 T DK 97905218T DK 0881901 T3 DK0881901 T3 DK 0881901T3
Authority
DK
Denmark
Prior art keywords
pct
combination
active substances
substances containing
antithrombotic agent
Prior art date
Application number
DK97905218T
Other languages
English (en)
Inventor
Andre Bernat
Jean-Marc Herbert
Pierre Savi
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9489354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0881901(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of DK0881901T3 publication Critical patent/DK0881901T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK97905218T 1996-02-19 1997-02-17 Kombination af aktive stoffer, der indeholder clopidogrel og et antithrombotisk middel DK0881901T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9602027A FR2744918B1 (fr) 1996-02-19 1996-02-19 Nouvelles associations de principes actifs contenant un derive de thieno(3,2-c)pyridine et un antithrombotique
PCT/FR1997/000296 WO1997029753A1 (fr) 1996-02-19 1997-02-17 Nouvelles associations de principes actifs contenant du clopidogrel et un antithrombotique

Publications (1)

Publication Number Publication Date
DK0881901T3 true DK0881901T3 (da) 2002-10-07

Family

ID=9489354

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97905218T DK0881901T3 (da) 1996-02-19 1997-02-17 Kombination af aktive stoffer, der indeholder clopidogrel og et antithrombotisk middel

Country Status (28)

Country Link
US (1) US5989578A (da)
EP (1) EP0881901B1 (da)
JP (1) JP3662028B2 (da)
KR (1) KR100295345B1 (da)
CN (1) CN1116042C (da)
AT (1) ATE218870T1 (da)
AU (1) AU715655B2 (da)
BR (1) BR9707556A (da)
CA (1) CA2246289C (da)
CZ (1) CZ292363B6 (da)
DE (2) DE122010000030I2 (da)
DK (1) DK0881901T3 (da)
EE (1) EE03513B1 (da)
ES (1) ES2176684T3 (da)
FR (1) FR2744918B1 (da)
HU (1) HU225036B1 (da)
IL (1) IL125848A (da)
IS (1) IS1892B (da)
NO (2) NO317747B3 (da)
NZ (1) NZ331444A (da)
PL (1) PL187292B1 (da)
PT (1) PT881901E (da)
RU (1) RU2184547C2 (da)
SI (1) SI0881901T1 (da)
SK (1) SK284285B6 (da)
TR (1) TR199801608T2 (da)
UA (1) UA51695C2 (da)
WO (1) WO1997029753A1 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002506024A (ja) * 1998-03-13 2002-02-26 メルク エンド カムパニー インコーポレーテッド 急性冠動脈虚血症候群および関連状態に対する併用療法および組成物
JP4588877B2 (ja) 1998-06-17 2010-12-01 ブリストル−マイヤーズ スクイブ カンパニー Ａｄｐ−受容体抗血小板物質と抗高血圧薬の組合せ投与による脳梗塞の予防
US6509348B1 (en) 1998-11-03 2003-01-21 Bristol-Myers Squibb Company Combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination
FR2792836B3 (fr) 1999-04-30 2001-07-27 Sanofi Sa Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel
FR2797400A1 (fr) * 1999-08-11 2001-02-16 Sanofi Synthelabo Associations a activite anti-thrombotique constituees de l'hydrogenosulfate de clopidogrel et d'un antagoniste des recepteurs gpiib/iiia et les compositions pharmaceutiques les contenant
PL206138B1 (pl) * 2000-12-25 2010-07-30 Daiichi Sankyo Company Limiteddaiichi Sankyo Company Limited Kompozycja farmaceutyczna zawierająca aspirynę oraz zestaw i zastosowanie składników kompozycji
SE0101932D0 (sv) * 2001-05-31 2001-05-31 Astrazeneca Ab Pharmaceutical combinations
FR2832929A1 (fr) * 2001-12-05 2003-06-06 Sanofi Synthelabo Compositions pharmaceutiques contenant un agent antithrombotique et un derive d'amines cycliques
AU2003270861A1 (en) * 2002-10-02 2004-04-23 Bristol-Myers Squibb Company Novel combination of a factor xa inhibitor and clopidogrel
EP1641492B1 (en) 2003-07-08 2011-12-14 Accumetrics, Inc. Controlled platelet activation to monitor therapy of adp antagonists
US20070243632A1 (en) * 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
HUP0400982A2 (en) * 2004-05-17 2006-08-28 Chemor Kutato New veterinary product for honeybees
US20060222640A1 (en) * 2005-03-29 2006-10-05 Boehringer Ingelheim International Gmbh New pharmaceutical compositions for treatment of thrombosis
RU2303980C2 (ru) * 2005-06-03 2007-08-10 ОАО "Щелковский витаминный завод" Лекарственная форма с антиагрегационным действием и способ ее изготовления
AU2006292946B2 (en) * 2005-09-21 2009-12-10 Chong Kun Dang Pharmaceutical Corp. Novel resinate complex of s-clopidogrel and production method thereof
WO2008048083A1 (es) * 2006-10-17 2008-04-24 Espinosa Abdala Leopoldo De Je Composiciones farmacéuticas para el tratamiento de enfermedades tromboembólicas
DE102006051625A1 (de) 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
RU2470636C2 (ru) * 2007-04-27 2012-12-27 Сайдекс Фамэсьютиклз, Инк. Композиция клопидогреля и сульфоалкилового эфира циклодекстрина (варианты) и способы лечения заболеваний посредством названной композиции (варианты)
EP2255797A4 (en) * 2008-02-22 2011-09-07 Hanall Biopharma Co Ltd COMPOSITE PREPARATION
DE102008032361A1 (de) * 2008-07-10 2010-01-21 Csl Behring Gmbh Der Einsatz von Faktor VIII und vWF bzw. vWF-enthaltenden Konzentraten zur Therapie der durch Thrombocyten-Inhibitoren induzierte Koagulopathie
ES2769949T3 (es) 2009-05-13 2020-06-29 Cydex Pharmaceuticals Inc Composiciones farmacéuticas que comprenden prasugrel y derivados de ciclodextrina y métodos de preparación y uso de las mismas
EA021588B1 (ru) 2009-06-25 2015-07-30 Тетра Сиа Бетаиновые соли ацетилсалициловой кислоты
US8563574B2 (en) 2009-12-07 2013-10-22 Academic Pharmaceuticals, Inc. Parenteral formulation of clopidogrel
CN102389436A (zh) * 2011-09-09 2012-03-28 北京阜康仁生物制药科技有限公司 一种抗血小板聚集的药物组合物
KR101675501B1 (ko) * 2011-11-02 2016-11-14 한국유나이티드제약 주식회사 클로피도그렐 및 아스피린의 복합제제
US8513278B2 (en) 2011-11-26 2013-08-20 Academic Pharmaceuticals, Inc. Parenteral dextrose formulation of clopidogrel
CN102406938A (zh) * 2011-11-29 2012-04-11 北京阜康仁生物制药科技有限公司 一种抗血栓的药物组合物
KR101473268B1 (ko) * 2012-03-09 2014-12-16 주식회사유한양행 클로피도그렐과 아스피린을 포함하는 약학 조성물 및 그의 제조방법
CN103720700A (zh) * 2012-10-10 2014-04-16 江苏威凯尔医药科技有限公司 含有阿斯匹林和维卡格雷的药用组合物
ES2657291T3 (es) 2013-04-22 2018-03-02 Csl Ltd. Un complejo covalente de factor de von Willebrand y factor VIII asociado por un puente disulfuro
KR101502588B1 (ko) 2013-05-01 2015-03-16 한국유나이티드제약 주식회사 클로피도그렐 및 아스피린의 복합제제
JP5905165B2 (ja) * 2013-08-02 2016-04-20 サノフイ アセチルサリチル酸およびクロピドグレルを含む医薬錠剤
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása
CN107698620A (zh) 2015-06-23 2018-02-16 江苏天士力帝益药业有限公司 一种氘代噻吩并哌啶衍生物、制备方法及其应用
RU2745774C1 (ru) * 2020-08-14 2021-03-31 Алексей Викторович Марочков Способ лечения пациентов с новой коронавирусной инфекцией (covid-19)
US20230059869A1 (en) 2021-08-03 2023-02-23 Liqmeds Worldwide Limited Oral pharmaceutical solution of clopidogrel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2307538A1 (fr) * 1975-04-18 1976-11-12 Centre Etd Ind Pharma Nouveau medicament anti-agregant plaquettaire

Also Published As

Publication number Publication date
FR2744918A1 (fr) 1997-08-22
UA51695C2 (uk) 2002-12-16
CN1211922A (zh) 1999-03-24
DE69713287D1 (de) 2002-07-18
NZ331444A (en) 2001-04-27
IS1892B (is) 2003-10-20
KR19990087163A (ko) 1999-12-15
CZ249998A3 (cs) 1998-11-11
RU2184547C2 (ru) 2002-07-10
EP0881901B1 (fr) 2002-06-12
HUP9901144A2 (hu) 1999-09-28
PT881901E (pt) 2002-09-30
NO2010015I2 (no) 2012-11-12
AU715655B2 (en) 2000-02-10
PL187292B1 (pl) 2004-06-30
DE122010000030I1 (de) 2010-10-21
SK284285B6 (sk) 2005-01-03
HK1017850A1 (en) 1999-12-03
NO983812D0 (no) 1998-08-19
EE9800247A (et) 1999-02-15
US5989578A (en) 1999-11-23
FR2744918B1 (fr) 1998-05-07
SI0881901T1 (en) 2002-10-31
ES2176684T3 (es) 2002-12-01
IL125848A (en) 2000-11-21
CZ292363B6 (cs) 2003-09-17
TR199801608T2 (xx) 1998-11-23
KR100295345B1 (ko) 2001-08-07
HU225036B1 (en) 2006-05-29
JP3662028B2 (ja) 2005-06-22
EE03513B1 (et) 2001-10-15
HUP9901144A3 (en) 2001-04-28
SK110598A3 (en) 1999-01-11
AU1884497A (en) 1997-09-02
CA2246289C (fr) 2003-12-16
DE69713287T2 (de) 2002-12-19
IS4827A (is) 1998-08-18
WO1997029753A1 (fr) 1997-08-21
DE122010000030I2 (de) 2012-06-21
JPH11510818A (ja) 1999-09-21
NO317747B3 (no) 2011-10-03
IL125848A0 (en) 1999-04-11
CA2246289A1 (fr) 1997-08-21
NO983812L (no) 1998-10-09
PL327923A1 (en) 1999-01-04
ATE218870T1 (de) 2002-06-15
BR9707556A (pt) 1999-07-27
NO2010015I1 (no) 2010-07-26
NO317747B1 (no) 2004-12-13
CN1116042C (zh) 2003-07-30
EP0881901A1 (fr) 1998-12-09

Similar Documents

Publication Publication Date Title
DK0881901T3 (da) Kombination af aktive stoffer, der indeholder clopidogrel og et antithrombotisk middel
DE68925814D1 (de) Hydrogeniertes block-copolymer und dessen zusammensetzung
EE9800028A (et) Iprotroopiumsoolad, neid sisaldavad ravimkompositsioonid ja nende kasutamine
PT809498E (pt) Composicao farmaceutica para utilizacao topica contendo aciclovir e hidrocortisona
IS5409A (is) Útskipt karboxamídóþíasól, framleiðsla þeirra og lyfjablöndur sem innihalda þau
NO942835L (no) 1-benzensulfonyl-1,3-dihydro-2H-benzimidazol-2-on-derivater, fremstilling derav og farmasöytiske blandinger som inneholder dem
ZA9811445B (en) Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions.
NO950537D0 (no) Polysubstituerte 3-acylamino-5-fenyl-1,4-benzodiazepin-2-on-derivater, fremgangsmåter for fremstilling derav og farmasöytiske blandinger inneholdende dem
DK0732328T3 (da) Heterocykliske, aromatiske forbindelser, farmaceutiske og kosmetiske sammensætninger, der indeholder dem, og anvendelser
DE69808664D1 (de) Feuerfeste metall-silizid-legierung sputter-targets, dessen verwendung und herstellung
YU6401A (sh) Primena eletriptana za izradu leka za prevenciju učestanog javljanja migrene
DK0748222T3 (da) Hostestillende sammensætning, som indeholder hostestillende middel og benzydamin
IL110724A0 (en) Retroviral protease inhibitors, their preparation and pharmaceutical compositions containing them
DK0922703T3 (da) Substituerede heterocykliske benzocycloalkener og disses anvendelse som analgetisk virksomme stoffer
IT1294931B1 (it) Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella
YU39598A (sh) Upotreba duloksetina i njegova farmaceutska smeša
PT1052991E (pt) Utilizacao de loperamida para o tratamento de infeccoes microbianas
IT9048605A0 (it) Derivati della 1,2,3,4,-tetraidronaftilammina ad attivita' nootropica e composizioni farmaceutiche che li contengono.
ITMI911444A1 (it) Derivati dell'eserolina ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizuini farmaceutiche che li contengono.
ITMI911653A1 (it) Derivati dell'eseridina ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
ES1031864Y (es) Estructura modular perfeccionada para actividades deportivas, sociales y otras.
ITMI922832A1 (it) DERIVATI DELL'ESEROLINA AD ATTIVITAy ANTICOLINESTERASICA, PROCEDIMENTO PER LA LORO PREPARAZIONE E COMPOSIZIONI FARMACEUTICHE CHE LI CONTENGONO.
ZA942972B (en) New quinoxalinedione derivatives, their production and use in pharmaceutical agents.